Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
JAMA|July 10, 2003
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trialEdward Abraham, Konrad Reinhart, Steven Opal, et al.
JAMA|March 21, 2013
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialSteven M Opal, Pierre-Francois Laterre, Bruno Francois, et al.
Critical Care (London, England)|February 5, 2017
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patientsJordi Rello, Claus-Georg Krenn, Gottfried Locker, et al.
JAMA|October 3, 2019
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical TrialPierre-Francois Laterre, Scott M Berry, Allan Blemings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2020
The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy StudyJason A Roberts, Gavin M Joynt, Anna Lee, et al.
Intensive Care Medicine|August 13, 2025
Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapyJason A Roberts, Marta Ulldemolins, Xin Liu, et al.
Pageof 4